Literature DB >> 19161886

Heart failure decompensation and all-cause mortality in relation to percent biventricular pacing in patients with heart failure: is a goal of 100% biventricular pacing necessary?

Bruce A Koplan1, Andrew J Kaplan, Stan Weiner, Paul W Jones, Milan Seth, Shelly A Christman.   

Abstract

OBJECTIVES: The goal of this analysis was to determine the appropriate biventricular pacing target in patients with heart failure (HF).
BACKGROUND: Cardiac resynchronization therapy (CRT) decreases the risk of death and HF hospitalization. However, the appropriate amount of biventricular pacing is ill-defined.
METHODS: Mortality and HF hospitalization data from patients undergoing CRT in 2 trials (CRT RENEWAL [Cardiac Resynchronization Therapy Registry Evaluating Patient Response with RENEWAL Family Devices] and REFLEx [ENDOTAK RELIANCE G Evaluation of Handling and Electrical Performance Study]; n = 1,812) were analyzed in a post-hoc fashion. Subjects were grouped based on percent biventricular pacing quartiles with the use of Kaplan-Meier survival analysis.
RESULTS: Subjects were age 72 +/- 11 years; 72% were men and 67% had coronary artery disease. Subjects paced 93% to 100% (quartiles 2 to 4) had a 44% reduction in hazard of an event compared with subjects paced 0% to 92% (quartile 1; hazard ratio [HR]: 0.56, p < 0.00001). Subjects paced 98% to 99% (quartile 3) had similar outcomes as subjects paced 93% to 97% (quartile 2; HR: 0.97, p = 0.82). Subjects paced 100% (quartile 4) had similar outcomes as subjects paced 98% to 99% (HR: 0.78, p = 0.17). There was a significant interaction between a history of atrial arrhythmia and percent pacing. Subjects with a history of atrial arrhythmia were more likely to be paced < or =92% (p < 0.001).
CONCLUSIONS: For CRT patients in this retrospective analysis, the greatest magnitude of benefit was observed with >92% biventricular pacing.

Entities:  

Mesh:

Year:  2009        PMID: 19161886     DOI: 10.1016/j.jacc.2008.09.043

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  47 in total

1.  Remote heart failure monitoring.

Authors:  William T Abraham
Journal:  Curr Treat Options Cardiovasc Med       Date:  2013-10

2.  Cardiac resynchronization therapy.

Authors:  Joseph S Owen; Sammy Khatib; Daniel P Morin
Journal:  Ochsner J       Date:  2009

Review 3.  Cardiac resynchronization therapy: history, present status, and future directions.

Authors:  Leeor M Jaffe; Daniel P Morin
Journal:  Ochsner J       Date:  2014

4.  Cardiac resynchronization therapy and outcomes in patients with left ventricular assist devices: a systematic review and meta-analysis.

Authors:  Dinesh Chandra Voruganti; Alexandros Briasoulis; Mohsan Chaudhry; Paulino Alvarez; Vlad Cotarlan; Jay K Bhama; Michael Giudici
Journal:  Heart Fail Rev       Date:  2019-03       Impact factor: 4.214

Review 5.  Clinical, laboratory, and pacing predictors of CRT response.

Authors:  Jagdesh Kandala; Robert K Altman; Mi Young Park; Jagmeet P Singh
Journal:  J Cardiovasc Transl Res       Date:  2012-02-24       Impact factor: 4.132

6.  One-year outcome after CRT implantation in NYHA class IV in comparison to NYHA class III patients.

Authors:  Andreas Schuchert; Carmine Muto; Themistoklis Maounis; Robert Frank; Rita Omega Ella; Alexander Polauck; Luigi Padeletti
Journal:  Clin Res Cardiol       Date:  2013-03-31       Impact factor: 5.460

7.  Cardiac resynchronization therapy update: evolving indications, expanding benefit?

Authors:  C Butcher; Y Mareev; V Markides; M Mason; T Wong; J G F Cleland
Journal:  Curr Cardiol Rep       Date:  2015-10       Impact factor: 2.931

8.  Visualization of Cardiac Implantable Electronic Device Data for Older Adults Using Participatory Design.

Authors:  Ryan Ahmed; Tammy Toscos; Romisa Rohani Ghahari; Richard J Holden; Elizabeth Martin; Shauna Wagner; Carly Daley; Amanda Coupe; Michael Mirro
Journal:  Appl Clin Inform       Date:  2019-09-18       Impact factor: 2.342

Review 9.  Atrial fibrillation and conduction system disease: the roles of catheter ablation and permanent pacing.

Authors:  Anand Thiyagarajah; Dennis H Lau; Prashanthan Sanders
Journal:  J Interv Card Electrophysiol       Date:  2018-08-03       Impact factor: 1.900

10.  Expanding indications for resynchronization therapy.

Authors:  Christophe Leclercq; Nathalie Behar; Philippe Mabo; Jean-Claude Daubert
Journal:  Curr Cardiol Rep       Date:  2012-10       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.